We obtained overlapping genes between Danshen compounds and dyslipidemia, and through a PPI network analysis, key target genes such as JAK2, STAT3, PI3K, AKT1, and TLR4 were acquired. This evidence concerns the gene AKT1 and metabolic syndrome.